DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

Express Scripts (NASDAQ: ESRX)



company name or ticker
Company Photos
(Click to zoom)

CVS Health Corporation: Trading Below Fair Value And Strong Dividend Growth

Is It Time to Buy Express Scripts Stock?

Express Scripts could see demand growth thanks to the launch of high-priced medicine, but that may not mean that now is the right time to buy.

UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

Benzinga's Top Downgrades

Analysts' Actions: Express Scripts, JDS Uniphase, Omnicare and More

How Will This Analyst Downgrade Affect Express Scripts (ESRX) Stock Today?

Top Analyst Upgrades and Downgrades: JDSU, JD.com, Palo Alto, Petrobras, SeaWorld, Twitter, Yandex a

Top Analyst Upgrades and Downgrades: JDSU, JD.com, Palo Alto, Petrobras, SeaWorld, Twitter, Yandex and More

How To Evaluate Express Scripts' Timeliness

Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks

Teva Pharmaceutical's reslizumab may some day offer a new treatment option for moderate and severe asthma patients.

Stock of the Week: Express Scripts (ESRX)

See More Articles...